Overview
- 176 inspections across 166 sites are on record.
- 432 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2020-08-14.
At a glance
Inspections
176
Sites
166
Observations
432
Career since
Dec 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| BioCorRx Inc | 14 Aug 2020 | OTHER | On file |
| John Pinches, III, DO | 15 Jul 2020 | Human Drugs | |
| Alturas Analytics, Inc. | 5 May 2020 | Human Drugs | On file |
| Collaborative Neuroscience Network, LLC | 10 Mar 2020 | Human Drugs | |
| Spectrum Pharmaceuticals, Inc. | 12 Feb 2020 | Human Drugs | On file |
Sites inspected
BioCorRx IncAnaheim, United States1 insp.
John Pinches, III, DOBuena Park, United States1 insp.
Alturas Analytics, Inc.Moscow, United States1 insp.
Collaborative Neuroscience Network, LLCGarden Grove, United States1 insp.
Spectrum Pharmaceuticals, Inc.Boston, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
James P Stallings5 shared
Sean P Desbrow5 shared
Kimberly M Lichter4 shared
Lavender M Huskey3 shared
Ana Djurdjevic3 shared
Eileen T Dupont3 shared
Marilyn S Babu2 shared
Sara J Dent Acosta2 shared
Dyana K Stone2 shared
Ka L Wong2 shared
Full investigator report
Get the verbatim findings behind Angela Shepas' 432 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site